Literature DB >> 20856613

Undertreatment of cancer patients with chemotherapy is a global concern.

Gary H Lyman.   

Abstract

Entities:  

Year:  2008        PMID： 20856613      PMCID： PMC2794003          DOI： 10.1200/JOP.0831502

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  17 in total

1.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors:  Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2006-05-08       Impact factor: 44.544

2.  Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.

Authors:  Marco Colleoni; Sigui Li; Richard D Gelber; Karen N Price; Alan S Coates; Monica Castiglione-Gertsch; Aron Goldhirsch
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial.

Authors:  Jacques Bonneterre; Henri Roché; Pierre Kerbrat; Alain Brémond; Pierre Fumoleau; Moïse Namer; Marie-Josèphe Goudier; Simon Schraub; Pierre Fargeot; Isabelle Chapelle-Marcillac
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

4.  Undertreatment of obese women receiving breast cancer chemotherapy.

Authors:  Jennifer J Griggs; Melony E S Sorbero; Gary H Lyman
Journal:  Arch Intern Med       Date:  2005-06-13

5.  Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey.

Authors:  Kathryn M Field; Suzanne Kosmider; Michael Jefford; Michael Michael; Ross Jennens; Michael Green; Peter Gibbs
Journal:  J Oncol Pract       Date:  2008-05       Impact factor: 3.840

6.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.

Authors:  Jennifer J Griggs; Eva Culakova; Melony E S Sorbero; Michelle van Ryn; Marek S Poniewierski; Debra A Wolff; Jeffrey Crawford; David C Dale; Gary H Lyman
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

7.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

Authors:  Gary H Lyman; David C Dale; Jonathan Friedberg; Jeffrey Crawford; Richard I Fisher
Journal:  J Clin Oncol       Date:  2004-09-20       Impact factor: 44.544

8.  Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).

Authors:  E Lepage; C Gisselbrecht; C Haioun; C Sebban; H Tilly; A Bosly; P Morel; R Herbrecht; F Reyes; B Coiffier
Journal:  Ann Oncol       Date:  1993-09       Impact factor: 32.976

9.  Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.

Authors:  Gary H Lyman; David C Dale; Jeffrey Crawford
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

Review 10.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Gary H Lyman
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544
View more
  5 in total

1.  Caring for the elderly cancer patient: training the next generation of oncologists.

Authors:  Gary H Lyman
Journal:  J Oncol Pract       Date:  2008-07       Impact factor: 3.840

2.  See you in chicago.

Authors:  Douglas W Blayney
Journal:  J Oncol Pract       Date:  2008-05       Impact factor: 3.840

3.  Dose intensity in early-stage breast cancer: a community practice experience.

Authors:  Robert L Bretzel; Ralph Cameron; Marc Gustas; Maria A Garcia; Heather K Hoffman; Rosalind Malhotra; Karen Miller; Janine Prime; Anne Favret
Journal:  J Oncol Pract       Date:  2009-11       Impact factor: 3.840

Review 4.  How to implement a geriatric assessment in your clinical practice.

Authors:  Schroder Sattar; Shabbir M H Alibhai; Hans Wildiers; Martine T E Puts
Journal:  Oncologist       Date:  2014-09-03

5.  Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer.

Authors:  Esse I H Akpo; Irshaad R Jansen; Edith Maes; Steven Simoens
Journal:  Front Pharmacol       Date:  2017-09-13       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.